Antipsychotics Flashcards

1
Q

What are antipsychotics?

A
  • Drugs that reduce psychomotor excitement

* Controls symptoms of psychosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Therapeutic uses of antipsychotics

A
  1. Hallucination
  2. Delusions
  3. Agitation
  4. Psychomotor excitement
    - Mania
    - Schizophrenia
    - Psychosis 2ndary to medical condition
  5. Prophylaxis – prevent relapse of psychotic illness/episodes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MOA of antipsychotics

A

• Blockade of DA pathways - reduces irrational behavior, agitation and aggressiveness along with psychotic symptomology
• In schizophrenia, DA overactivity is not the only abnormality
- Monoaminergic (5-HT) and aminoacid (glutamate) neurotransmitter systems may also be affected
• Only positive symptoms (hallucinations, aggression etc.) are linked with DA overactivity
• Negative symptoms (apathy, cognitive deficit etc.) are not necessarily linked with DA, however reduction of dopaminergic neurotransmission is the major mechanism of antipsychotic action.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Effect of DA antagonism on CVS

A

Hypotension (primarily postural) - d/t central and peripheral action on sympathetic tone

QT prolongation

Suppression of T wave (ECG)

Arrythmia (overdose)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Effect of DA antagonism on endocrine system

A

Increased prolactin release - d/t blockage of DA which has an inhibitory action on pituitary lactotrophs - gynaecomastia and galactorrhea, amenorrhea, hyperprolactinemia

Deacreased ADH - increased urine volume

Impair glucose tolerance - aggravate diabets, weight gain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Name the two classes of anti-psychotics

A

Typical

Atypical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are typical antipsychotics? Give examples

A
•	Work primarily through inhibition of D2 receptor – extrapyramidal side effects
•	Reduced tendency to induce neurologic movement disorder 
•	Examples: 
a)	Chlorpromazine
b)	Thioridazine
c)	Fluphenazine
d)	Haloperidol
e)	Zuclopentixol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are atypical antipsychotics?

A
•	Second generation anti-psychotics with weak dopamine blocking potential but strong 5-HT2 antagonistic activity. 
•	Minimal extrapyramidal SE and tardive dyskinesia 
•	Examples
a)	Risperidone 
b)	Clozapine 
c)	Olanzapine 
d)	Aripiprazole
e)	Quetiapine 
f)	Amisulpride
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which class is used as the first line treatment?

A

Atypical antipsychotics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Chlorpromazine (receptors involved and SEs)

A
  • Receptor involved: alpha1, H1, muscarinic cholinergic
  • SE: sedation (blockade of alpha1 and histamine), hypotension (a1), anticholinergic (dry mouth, constipation, urinary incontinence), EPSE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Haloperidol (receptors involved and SEs)

A
  • Receptor involved: dopamine receptor

* SE: high risk of EPSE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risperidone (receptors involved and SEs)

A
  • Receptors involved: 5-HT2, D2 and alpha1

* SE: mild sedation, hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Olanzapine (receptors involved and SEs)

A
  • Receptors involved: D2 (weak), anticholinergic, H1 (strong)
  • SE: sedation (H1), dry mouth, constipation, weight gain, metabolic syndrome (worsens diabetes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Quetiapine (receptors involved and SEs)

A

• Receptors: 5-HT, D2, A1 and 2, H1, D2 (low)
• SE: sedation, postural hypotension, urinary retention/incontinence
- Extremely minimal EPSE and hyperprolactinaemic SE as D2 blocking activity is low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Aripiprazole (receptors involved and SEs)

A
  • Receptors: partial dopamine agonist at D2 receptor, but antagonist at 5-HT2 receptor
  • SE: nausea, dyspepsia, constipation, light-headedness
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clozapine

A

(used when unresponsive to other medication)
• Receptors: D2 (weak), 5-HT2 (strong), H1, alpha and muscarinic
• SE: sedation, potent anticholinergic, hypersalivation, agranulocytosis, bloody dyscrasia, precipitation of diabetes, myocarditis

17
Q

What monitoring is to be done when patient is on clozapine?

A
•	Regular blood tests are mandatory for a patient on clozapine to monitor the white cell count
-	First 6 months – weekly
-	Next 6 months – fortnightly 
-	Thereafter – every 4 weeks 
-	For one month after cessation
•	ECG
18
Q

List the extrapyramidal SE seen with conventional antipsychotics

A
  1. Acute dystonia – painful contractions of muscles in neck, jaw or eyes (more common in men)
  2. Parkinsonism – reduced facial movements, shuffling gait, stiffness, tremor
  3. Akathisia – involuntary restlessness (typically in the legs)
  4. Tardive dyskinesia – involuntary grimacing movements of the face, tongue or upper body
19
Q

List the general side effects seen with the use of atypical antipsychotics

A
  1. Weight gain - worst with clozapine and olanzapine
  2. Hyperglycaemia and type 2 diabetes - can induce this along with insulin resistance
  3. Metabolic syndrome the above two + dyslipidemia and HTN
  4. Stroke - caution with elderly patients and in dementia
20
Q

Treating acute dystonia

A

Stop antipsychotic AND/OR give anticholinergic

21
Q

Treatment of parkinsonism

A

Change antipsychotic - to something less D2 related

22
Q

Treating Akathisia

A

Reduce/ change antipsychotic

23
Q

Treating tardive dyskinesia

A

Sometimes reducing antipsychotics make it worse - not treatable

Therefore, prevent it rather than let it develop.

24
Q

Choosing antipsychotic

A

No real difference in efficacy

Consider previous use of antipsychotic - use what has helped before

Consider preexisting comobrbidties - diabetes, overwieght, parkinsons

Consider patient concerns for SE.

25
Q

Use of depot

A

a) Detained patients who lack insight and will not take oral regularly
b) Informal patients who recognise they can be irregular taking tablets or who prefers infrequent injection